Поиск
RESULTS OF THE ROUND TABLE K+31 WEST “NON-ONCOLOGICAL PROBLEMS OF CANCER PATIENTS”
Results of the round table K+31 West “Non-oncological problems of cancer patients”
177LU-PSMA-617 VERSUS ANDROGEN AXIS INHIBITOR IN THE TREATMENT OF TAXANE-NAÏVE ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
177Lu-PSMA-617 versus androgen axis inhibitor in the treatment of taxane-naïve advanced metastatic castration-resistant prostate cancer According to existing recommendations, the emergence of castration resistance of cancer dictates the need to switch to a ...
ARE THE LONG-TERM ONCOLOGIC OUTCOMES DIFFERENT BETWEEN NEOADJUVANT CHEMOTHERAPY AND ADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER?
Are the long-term oncologic outcomes different between neoadjuvant chemotherapy and adjuvant chemotherapy in locally advanced breast cancer? Farhad Ghasemi and Muriel Braxton (Western University, Ontario, Canada) analyzed six randomized controlled trials ( ...
NEOADJUVANT THERAPY WITH NIVOLUMAB + RELATLIMAB OR NIVOLUMAB + IPILIMUMAB IN TRIPLE-NEGATIVE BREAST CANCER
Neoadjuvant therapy with nivolumab + relatlimab or nivolumab + ipilimumab for triple-negative breast cancer with high levels of tumor-infiltrating lymphocytes Iris Nederlof and colleagues from the Netherlands Cancer Institute in Amsterdam recently ...
THE INFLUENCE OF PROGESTERONE RECEPTOR LEVELS ON PROGNOSIS IN PATIENTS WITH ADVANCED BREAST CANCER
Impact of progesterone receptor levels on prognosis in patients with advanced breast cancer with high levels of estrogen receptors and HER2− receiving endocrine therapy plus a CDK4/6 inhibitor in first line BEFORE THE CDK4/6 INHIBITOR ERA, the effect of PR ...
THE INFLUENCE OF PROGESTERONE RECEPTOR LEVELS ON PROGNOSIS IN PATIENTS WITH ADVANCED BREAST CANCER
Impact of progesterone receptor levels on prognosis in patients with advanced breast cancer with high levels of estrogen receptors and HER2− receiving endocrine therapy plus a CDK4/6 inhibitor in first line BEFORE THE CDK4/6 INHIBITOR ERA, the effect of PR ...
BREAKTHROUGH IN ONCOLOGY: TREATMENT OF METASTATIC MELANOMA WITH THE DRUG "NURDATI"
Breakthrough in oncology: treatment of metastatic melanoma with the drug "Nurdati"
